Key result
Leo patch detects higher nocturnal HR and RR on day one post-discharge in severe pediatric asthma.
Why the study?
Wearable sensors enable longitudinal physiological monitoring, but the ability of a wireless wearable patch to capture continuous home physiological data in children required evaluation.
Can the Leo wireless wearable patch effectively capture longitudinal physiological data and be comfortably worn by children post-discharge for asthma exacerbation?
Observational (n=15)
Can the Leo wireless wearable patch effectively capture longitudinal physiological data and be comfortably worn by children post-discharge for asthma exacerbation?
The Leo wireless wearable patch is feasible for continuous remote monitoring of physiological data in children post-discharge, with acceptable comfort and minor skin irritation.
Answers are grounded in this paper and cite their sources.
Supports wearable patch feasibility for post-discharge monitoring in pediatric asthma; leaves open impact on management or outcomes.
Remote patient monitoring (RPM) is an innovative strategy to promote health and improve patient management and care. Recent advances in healthcare technologies have seen the emergence of wearable sensors allowing longitudinal physiological measurements in any environment. This paper introduces a wireless wearable patch ‘Leo’ for continuous remote monitoring of physiological data at home and healthcare settings. This includes single lead ECG, chest impedance, heart rate (HR), respiration rate (RR) and body posture. To test Leo’s ability to capture longitudinal physiological data at home, 15 children experiencing acute severe asthma exacerbations were recruited during their emergency department (ED) visits. Participants wore the Leo device for 7 (+/-2) days post-hospital discharge. Nocturnal RR and HR and variability were higher during the first half of the night on Day1 compared to Day7 (p<0.005). Participants also completed a usability questionnaire and reported the patch wear to be comfortable (average score of 3.3 out of 5) and easy to wear during the night (average score of 3.5 out of 5) with 5/15 (33%) reported very slight barely perceptible skin irritation/redness and 2 (13%) reported well defined skin irritation and redness.Clinical Relevance— These results highlight the potential use of the Leo device in clinical practice for continuous un-obstructive monitoring of diseased populations, such as asthma.
No takes yet. Share an insight, caveat, or question.
Javed et al. (2023) conducted an observational in Acute severe asthma exacerbations (n=15). Wireless wearable patch 'Leo' was evaluated on Nocturnal RR and HR and variability (p=<0.005).
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: